Online citations, reference lists, and bibliographies.
← Back to Search

Recombinase‐mediated Cassette Exchange (RMCE) For Monoclonal Antibody Expression In The Commercially Relevant CHOK1SV Cell Line

L. Zhang, Mara C. Inniss, Shu’e Han, M. Moffat, Heather Jones, Baohong Zhang, Wendy L Cox, J. Rance, R. Young
Published 2015 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
To meet product quality and cost parameters for therapeutic monoclonal antibody (mAb) production, cell lines are required to have excellent growth, stability, and productivity characteristics. In particular, cell line generation stability is critical to the success of a program, especially where high cell line generation numbers are required for large in‐market supply. However, a typical process for developing such cell lines is laborious, lengthy, and costly. In this study, we applied a FLP/FRT recombinase‐mediated cassette exchange (RMCE) system to build a site‐specific integration (SSI) system for mAb expression in the commercially relevant CHOK1SV cell line. Using a vector with a FRT‐flanked mAb expression cassette, we generated a clonal cell line with good productivity, long‐term production stability, and low mAb gene‐copy number indicating the vector was located in a ‘hot‐spot.’ A SSI host cell line was made by removing the mAb genes from the ‘hot‐spot’ by RMCE, creating a ‘landing pad’ containing two recombination cassettes that allow targeting of one or two copies of recombinant genes. Cell lines made from this host exhibited excellent growth and productivity profiles, and stability for at least 100 generations in the absence of selection agents. Importantly, while clones containing two copies had higher productivity than single copy clones, both were stable over many generations. Taken together, this study suggests the use of FLP‐based RMCE to develop SSI host cells for mAb production in CHOK1SV offers significant savings in both resources and overall cell line development time, leading to a shortened ‘time‐to‐clinic’ for therapeutic mAbs. © 2015 American Institute of Chemical Engineers Biotechnol. Prog., 31:1645–1656, 2015
This paper references
Expression in COS cells of a mouse-human chimaeric B72.3 antibody.
N. Whittle (1987)
Basic local alignment search tool.
S. Altschul (1990)
Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase.
B. Sauer (1990)
Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci.
T. Schlake (1994)
Drug therapy : Ganciclovir
C. Crumpacker (1996)
Double-reciprocal crossover mediated by FLP-recombinase: a concept and an assay.
J. Seibler (1997)
DNA cassette exchange in ES cells mediated by Flp recombinase: an efficient strategy for repeated modification of tagged loci by marker-free constructs.
J. Seibler (1998)
Cytogenetic analysis of chimeric antibody-producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure.
S. Kim (1999)
Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange.
Y. Feng (1999)
Site-specific gene targeting for gene expression in eukaryotes.
C. Gorman (2000)
Construction of engineered CHO strains for high-level production of recombinant proteins
M. Kito (2002)
Stability of protein production from recombinant mammalian cells
L. Barnes (2003)
Evaluation of stable and highly productive gene amplified CHO cell line based on the location of amplified genes
T. Yoshikawa (2004)
Production of recombinant protein therapeutics in cultivated mammalian cells
F. Wurm (2004)
Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools.
C. Coates (2005)
Antibody production.
J. Birch (2006)
Recommended Method for Chromosome Exploitation: RMCE-based Cassette-exchange Systems in Animal Cell Biotechnology
A. Oumard (2006)
Stochastic mRNA Synthesis in Mammalian Cells
A. Raj (2006)
Identification of transgene integration loci of different highly expressing recombinant CHO cell lines by FISH
Christine Lattenmayer (2006)
Toward more efficient protein expression : keep the message simple
S Kalwy (2006)
Trying to Consistently Find the Sweet Spot for Antibody Expression
R DuBridge (2007)
Use of Flp-mediated cassette exchange in the development of a CHO cell line stably producing erythropoietin.
M. Kim (2008)
BLAST+: architecture and applications
C. Camacho (2009)
Intraclonal Protein Expression Heterogeneity in Recombinant CHO Cells
Warren Pilbrough (2009)
The molecular basis for stability of heterochromatin-mediated silencing in mammals
Kyoko Hiragami-Hamada (2009)
Using microarray technology to select housekeeping genes in Chinese hamster ovary cells.
S. Bahr (2009)
BLAST 1 : architecture and applications
C Camacho (2009)
Multiplexing RMCE: versatile extensions of the Flp-recombinase-mediated cassette-exchange technology.
Soeren Turan (2010)
Utilization of Site-Specific Recombination for Generating Therapeutic Protein Producing Cell Lines
M. Campbell (2010)
Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system.
H. Zhou (2010)
An accumulative site‐specific gene integration system using cre recombinase‐mediated cassette exchange
Y. Kameyama (2010)
Strategies for selecting Recombinant CHO cell lines for cGMP manufacturing: Realizing the potential in bioreactors
Alison J. Porter (2010)
Inventors; Regeneron Pharmaceuticals Inc., assignee. Enhanced Expression and Stability Regions. US patent 7,771
G Chen (2010)
Repeated integration of antibody genes into a pre-selected chromosomal locus of CHO cells using an accumulative site-specific gene integration system
Y. Kawabe (2011)
High-level transgene expression by homologous recombination-mediated gene transfer
Mélanie Grandjean (2011)
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
X. Xu (2011)
Fast gapped-read alignment with Bowtie 2
B. Langmead (2012)
Fast identification of reliable hosts for targeted cell line development from a limited‐genome screening using combined φC31 integrase and CRE‐Lox technologies
Y. Crawford (2013)

This paper is referenced by
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation
E. Fung (2021)
Multiplexed engineering glycosyltransferase genes in CHO cells via targeted integration for producing antibodies with diverse complex-type N-glycans
Ngan N. T. Nguyen (2021)
Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific molecule
Barbara Tevelev (2021)
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors
Adam R. Root (2021)
A pooled CRISPR/AsCpf1 screen using paired gRNAs to induce genomic deletions in Chinese hamster ovary cells
Valerie Schmieder (2021)
Development of a targeted integration Chinese hamster ovary host directly targeting either one or two vectors simultaneously to a single locus using the Cre/Lox recombinase‐mediated cassette exchange system
Domingos Ng (2021)
Epigenomic features revealed by ATAC‐seq impact transgene expression in CHO cells
Zion Lee (2021)
CHOK1SV GS‐KO SSI expression system: A combination of the Fer1L4 locus and glutamine synthetase selection
M. Feary (2021)
Multi-copy targeted integration for accelerated development of high-producing CHO cells.
D. Sergeeva (2020)
Chromatin-modifying elements for recombinant protein production in mammalian cell systems
Xiao Guo (2020)
The use of site-specific recombination and cassette exchange technologies for monoclonal antibody production in Chinese Hamster ovary cells: retrospective analysis and future directions
K. Srirangan (2020)
High‐resolution three‐dimensional chromatin profiling of the Chinese hamster ovary cell genome
S. Bevan (2020)
HK022 bacteriophage Integrase mediated RMCE as a potential tool for human gene therapy
A. Elias (2020)
CHO Cell Line Development and Engineering via Site-specific Integration: Challenges and Opportunities
S. Shin (2020)
A Site-Specific Integration Reporter System that Enables Rapid Evaluation of CRISPR/Cas9-mediated Genome Editing Strategies in CHO Cells.
Nathaniel K Hamaker (2020)
Maximizing Antibody Production in a Targeted Integration Host by Optimization of Subunit Gene Dosage and Position.
Joe Carver (2020)
PTSelect™: A post-transcriptional technology that enables rapid establishment of stable CHO cell lines and surveillance of clonal variation.
Vandhana Muralidharan-Chari (2020)
Toward Shortened the Time-to-Market for Biopharmaceutical Proteins: Improved Fab Protein Expression Stability Using the Cre/lox System in a Multi-Use Clonal Cell Line.
Julita Balcerek (2020)
Systematic identification of safe harbor regions in the CHO genome through a comprehensive epigenome analysis
William Hilliard (2020)
Cell culture bioprocessing - the road taken and the path forward.
S. O’Brien (2020)
Dissecting N-Glycosylation Dynamics in Chinese Hamster Ovary Cells Fed-batch Cultures using Time Course Omics Analyses
M. Sumit (2019)
Application of Genetic Engineering in Biotherapeutics Development
Patrick G Schweickert (2019)
Quantitative Measurement of Heritability in the Pre-RNA World.
Norichika Ogata (2019)
Identification of process-relevant kinases in human amniotic production cells
Andreas Wagner (2019)
HIF-1 Signaling Pathway Implicated in Phenotypic Instability in a Chinese Hamster Ovary Production Cell Line.
Paulena L Lieske (2019)
[Biomanufacturing of monoclonal antibodies].
S. Joubert (2019)
Mitigating Clonal Variation in Recombinant Mammalian Cell Lines.
J. S. Lee (2019)
Utilizing a regulated targeted integration cell line development approach to systematically investigate what makes an antibody difficult to express
Tomofumi Tadauchi (2019)
Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins
X. Zhong (2019)
Development of an improved lentiviral based vector system for the stable expression of monoclonal antibody in CHO cells
Omid Mohammadian (2019)
A CRISPR/Cas9 based engineering strategy for overexpression of multiple genes in Chinese hamster ovary cells.
Peter Eisenhut (2018)
Beyond preclinical research: production of CHO-derived biotherapeutics for toxicology and early-phase trials by transient gene expression or stable pools
Matthew Stuible (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar